Daridorexant (Quviviq)

What is daridorexant?

Daridorexant is known as Quviviq in the United States, Europe, and Japan alike (クービビック on Japanese packaging). It belongs to the newest group of sleep medicines, the orexin receptor antagonists (DORA): instead of sedating the whole brain, it blocks orexin, the brain's wake-promoting messenger, so the brain can shift from wakefulness to sleep.

How is it different from other sleeping pills?

• Dependence and tolerance are unlikely: in the trials, stopping it didn't cause withdrawal symptoms
• Relatively short-acting: less of it is left in your system by morning, though some next-day effect is still possible
• Blocks the wake signal rather than sedating the brain as a whole: a different way of working from benzodiazepine and Z-drug sleeping pills
• Helps with both falling asleep and staying asleep

What is it used for in Japan?

Insomnia: both falling asleep and staying asleep.

What it targets: the whole night, with a relatively short action, so less of it is left in your system by morning.

How does it help?

By blocking the brain's wake signal, it helps you fall asleep and stay asleep. It works best alongside good sleep habits.

What should I tell my doctor before starting?

A few situations rule it out entirely; your doctor will choose something else if any of these apply:

• A past allergic reaction to daridorexant
• Severe liver problems
• Certain medicines that block how the body clears it (some antifungals like itraconazole, some antibiotics like clarithromycin, certain HIV and COVID medicines, and a few cancer medicines); always tell us your full medication list, including short courses

And tell your doctor first if any of these apply; these usually just need adjustments or a closer eye:

• Narcolepsy or cataplexy
• Other medicines cleared the same way (such as diltiazem, verapamil, erythromycin, or fluconazole); your doctor will decide whether the combination is suitable, and if so, a lower dose is used
• Carbamazepine, phenytoin, or rifampicin, which can weaken its effect, and some medicines whose levels it can raise, such as digoxin
• Moderate liver problems (a lower dose is used)
• A past brain injury, stroke, or other brain condition (the effect can be stronger)
• Serious lung or breathing problems, including sleep apnea
• Other sedating medicines, or regular alcohol use
• Pregnant, planning to be, or breastfeeding (see the section below)

How do I take it?

Once a night, right before bed, and only on nights you can give a full night to sleep.

• Take it immediately before lying down; avoid taking it with or just after a meal, which can delay the effect
• If you forget it, just skip that night. Never take a second dose in one night
• Avoid alcohol; the Japanese label warns that the two strengthen each other's effects on alertness

What side effects should I expect?

Most are mild. Not everyone gets them.

• Daytime drowsiness
• Headache
• Tiredness
• Nightmares, or vivid or unusual dreams

If anything is bothering you, tell your doctor; there's often a way to adjust.

Finally, one thing that is rare (most people never experience it) but good to know:

• A brief feeling of being unable to move while falling asleep or waking (sleep paralysis), or dream-like impressions at the edge of sleep. It passes on its own and isn't dangerous, but it can be startling; tell us and the plan can be adjusted

Will I become dependent? How do I stop safely?

No; like the other newer sleep medicines, daridorexant is unlikely to cause dependence or tolerance. In abuse-potential testing, the approved dose was rated above a dummy pill but lower than high doses of two other sleeping pills. The Japanese packaging still carries a standard notice that it may be habit-forming, so it is used at the prescribed dose and reviewed once sleep improves. It's best used for as long as you need it and no longer; the Japanese label asks for that review, and any change is made together.

Can I drive while taking it?

No. Don't drive after taking it, and be alert to any leftover drowsiness the next morning. The Japanese label instructs that patients on daridorexant shouldn't drive or operate dangerous machinery. Its relatively short action helps limit morning carryover, but some effect can remain the next morning, especially in the first days; if sleepiness lingers, tell your doctor.

What about pregnancy and breastfeeding?

Tell your doctor early; this is decided case by case. The Japanese label allows daridorexant in pregnancy only when the benefit is judged to outweigh the risk. With breastfeeding, it passes into milk, and the label leaves the decision to be weighed individually. Don't start, stop, or continue on your own. Our guides to medication in pregnancy and medication while breastfeeding cover the wider picture.